CLOV Stock: Price, Earnings History and SEC Filings
Clover Health Investments, Corp. (CLOV) last traded at $4.46, down 2.62% on the latest session and up 3.5% over the past month. In its most recent reported quarter (Mar 2026) earnings per share were $0.05 against an analyst estimate of $0.03, a beat of 66.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CLOV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Mar 2026 | May 6, 2026 | $0.05 | $0.03 | +66.67% |
| Dec 2025 | Feb 26, 2026 | $-0.10 | $-0.11 | +9.09% |
| Sep 2025 | Nov 4, 2025 | $-0.05 | $-0.03 | -66.67% |
CLOV beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
How CLOV reacts to earnings
Across its last 8 earnings releases, CLOV moved 9.5% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-05 | After close | +12.56% |
| 2026-05-06 | After close | +5.22% |
| 2026-02-26 | After close | -2.79% |
| 2025-08-05 | After close | -20.70% |
| 2025-05-06 | After close | +12.54% |
| 2025-02-27 | After close | -4.11% |
| 2024-11-06 | After close | -15.63% |
| 2024-08-05 | After close | -2.66% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
CLOV financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.9B | -$86M | -$69M | -4.4% | – |
| 2024 | $1.4B | -$43M | $33M | -3.1% | – |
| 2023 | $1.3B | -$213M | -$145M | -16.9% | $-0.44 |
| 2022 | $1.1B | -$340M | -$208M | -31.0% | $-0.71 |
| 2021 | $1.5B | -$588M | -$283M | -39.9% | $-1.42 |
| 2020 | $673M | -$136M | -$119M | -20.3% | $-1.54 |
| 2019 | $462M | -$364M | -$160M | -78.7% | $-4.14 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CLOV
- 8-K · Oct 9, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Sep 24, 2026Officer or director change, Financial statements and exhibits
- 8-K · Aug 20, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Aug 7, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 17, 2026Other events
- 8-K · Jun 18, 2026Other events
- 8-K · Jun 16, 2026Officer or director change
- 8-K · Jun 12, 2026Shareholder vote
- 8-K · Jun 10, 2026Other events
Insider filing activity
CLOV insiders filed 22 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
CLOV news
- 3 Big reasons to love Clover Health (CLOV)Oct 28, 2026 · finance.yahoo.com
- Clover Health climbs after Needham initiates coverage with Buy, $6 targetOct 28, 2026 · finance.yahoo.com
- Clover Health to Participate in Upcoming UBS Global Healthcare ConferenceOct 26, 2026 · finance.yahoo.com
- Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three StatesOct 19, 2026 · finance.yahoo.com
About Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) is a US-listed public company on Nasdaq. The SEC classifies its business as Hospital & Medical Service Plans. It is incorporated in DE. Its fiscal year ends in December.